NCT01394757View on ClinicalTrials.gov

Network Dysfunction, Schizophrenia and Pharmacological Magnetic Resonance Imaging (phMRI)

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Healthy Volunteers
Interventions
DRUG

Esketamine hydrochloride

Bolus: 15 mg/kg over 1 minute, followed by a maintenance infusion of 0.25 mg/kg/h for 19 minutes.

Trial Locations (1)

1090

Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT01394757 - Network Dysfunction, Schizophrenia and Pharmacological Magnetic Resonance Imaging (phMRI) | Biotech Hunter | Biotech Hunter